Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Christopher Flint Obrien Insider Profile
4 Followers
Christopher Flint Obrien, Former Chief Medical Officer at Neurocrine, holds 55.95K shares in Neurocrine (Ticker: NBIX).
Christopher Flint Obrien has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Christopher Flint Obrien's holdings
Insider Roles
Former Chief Medical Officer
Roles that Christopher Flint Obrien holds in companies
Most Profitable Insider Trade
The most profitable trade made by Christopher Flint Obrien
Christopher Flint Obrien's Trading History
List of latest transactions for each holding click on a transaction to see Christopher Flint Obrien's performance on stock
You May Also Like
Christopher Flint Obrien insider profile FAQ
What is the percentage of profitable transactions made by Christopher Flint Obrien?
The percentage of profitable transactions made by Christopher Flint Obrien is ―.
What is the average return per transaction made by Christopher Flint Obrien?
The average return per transaction made by Christopher Flint Obrien is ―.
What stocks does Christopher Flint Obrien hold?
Christopher Flint Obrien holds: NBIX stocks.
What was Christopher Flint Obrien’s latest transaction?
Christopher Flint Obrien latest transaction was an Uninformative Sell of $217.33K.
What was Christopher Flint Obrien's most profitable transaction?
Christopher Flint Obrien’s most profitable transaction was an Informative Buy of NBIX stock on November 6, 2017. The return on the trade was 43.00%.
What is Christopher Flint Obrien's role in Neurocrine?
Christopher Flint Obrien's role in Neurocrine is Former Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.